Related Experiment Video
Updated: Jun 1, 2026
08:53
Localization, Identification, and Excision of Murine Adipose Depots
Published on: December 4, 2014
Adipose tissue remodeling and obesity.
Kai Sun1, Christine M Kusminski, Philipp E Scherer
1Touchstone Diabetes Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8549, USA.
The Journal of Clinical Investigation
|June 3, 2011
Summary
Adipose tissue expansion shares similarities with tumor growth, requiring coordinated cell responses. Understanding these processes is key for developing therapies that support healthy tissue adaptation without promoting tumor progression.
Area of Science:
- Adipose tissue biology
- Cellular physiology
- Tumor microenvironment research
Background:
- Adipose tissue is the primary energy-storing organ, possessing unique expansion capabilities.
- Adipose tissue remodeling is crucial for its function, involving complex cellular interactions.
- Hypoxia is an early factor limiting healthy adipose tissue expansion due to rapid adipocyte growth.
Purpose of the Study:
- To explore the unique properties of adipose tissue enabling its expansion.
- To investigate the cellular mechanisms and cell type coordination during adipose expansion.
- To highlight the parallels between adipose expansion and solid tumor growth.
Main Methods:
- Analysis of cellular processes in adipose tissue expansion.
- Comparative study of adipose tissue adaptation and tumor growth mechanisms.
- Review of existing literature on adipocyte biology and tumor microenvironments.
Main Results:
- Adipose tissue expansion involves a coordinated response of endothelial precursor cells, immune cells, and preadipocytes.
- Hypoxia is a critical determinant limiting healthy adipose expansion.
- Significant similarities exist between adipose expansion and solid tumor growth.
Conclusions:
- The unique expansion capacity of adipose tissue relies on coordinated multicellular responses.
- The parallels between adipose expansion and tumor growth present therapeutic opportunities and challenges.
- Pharmacological interventions for adipose tissue adaptation may impact tumor growth.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:02Hypodermis
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:23Cellular Adaptation I: Introduction and Atrophy
Cells can adapt to environmental changes to maintain function and avoid injury, a process called cellular adaptation. Adapted cells exist in a reversible intermediate state with changes in size, number, phenotype, metabolism, or function. These responses help cells meet altered physiological or pathological demands; for example, enlargement of breast and uterine tissues during pregnancy. Early adaptations may enhance function, but persistent stress eventually causes tissue damage.Types of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.